2023
DOI: 10.1016/j.acuroe.2022.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Mitomycin C (MMC) has been tested both as induction therapy and single-shot adjuvant treatment [22,23]. Similarly, upper tract instillation with Bacillus Calmette-Guerin (BCG) has been considered in patients diagnosed with CIS using a similar schedule of instillations to that used in bladder cancer [24 ▪ ]. However, although the evidence is low, there is still uncertainty regarding the efficacy of endocavitary instillations in UTUC [1].…”
Section: Technologies To Improve the Efficacy Of Endoscopic Treatment...mentioning
confidence: 99%
“…Mitomycin C (MMC) has been tested both as induction therapy and single-shot adjuvant treatment [22,23]. Similarly, upper tract instillation with Bacillus Calmette-Guerin (BCG) has been considered in patients diagnosed with CIS using a similar schedule of instillations to that used in bladder cancer [24 ▪ ]. However, although the evidence is low, there is still uncertainty regarding the efficacy of endocavitary instillations in UTUC [1].…”
Section: Technologies To Improve the Efficacy Of Endoscopic Treatment...mentioning
confidence: 99%